Despite the hype around mHealth apps, the global mHealth app market is a niche market today. This will change over the course of the next five years as mHealth app publishers will more and more concentrate on business models that uses mHealth apps to sell connected devices and services. Traditional apps store revenue sources like paid downloads, in-app purchase and in-app advertisement will not be big enough to support the growing number of mHealth app publishers.
mHealth app users will remain the main driver for the next years allowing monetization strategies based on B2C business models. B2B models will become more important with health plans and HCPs integrating mHealth apps into the traditional healthcare market.
The report has five main parts:
Current market size: Provides current sizing of the mHealth market in terms of app numbers, app downloads and app store revenues for all mHealth apps or by app category. It identifies key application segments according to their current reach.
Country mHealth markets: The report looks into the mHealth app market of 56 countries. It profiles 10 countries which currently offer the best market potential for mHealth app publishers. It provides information about the country mHealth app market characteristics, such as which platform leads in the country and required download numbers to enter a top 5 ranking position.
17 mHealth business models: Describes performance of mHealth app publishers and their different monetization strategies. It identifies the most commonly used business models for mHealth apps and provides overview and best practice examples.
Top mHealth app publishers: Publishers background and performance differ significantly for the Health&Fitness and Medical app section. The report list and describes current most successful Health&Fitness and Medical app publishers. It analyzes their product portfolio and its performance.
mHealth market forecast: Estimates market size and market revenue until 2020. The market forecast provides a detailed outlook on demand and supply side of the mHealth app market in the next five years. It forecasts the number of mHealth app users, their platform preference and the number of downloads. The mHealth market revenue is provided for the main revenue sources.
Table of Content
3 Current status of the mHealth app market
3.1 mHealth app categories’ market share
3.2 Country market share by downloads and revenues
4 Top 10 mHealth countries’ profiles
4.5 United Kingdom
5 17 mHealth business models
5.1 Paid downloads
5.2 Device sales
5.3 Commission for appointments
5.4 Featured listing
5.5 One-time service fee for a consultation
5.6 Service subscription
5.9 Sponsored content or incentives
5.10 Contract work for 3rd parties
5.11 Technology licensing
5.12 Sales of source code/white label
5.13 Integrated in-app healthcare services
5.14 Sales of user tracking data
5.15 Affiliate sales
5.16 Processing fee
6 Top 10 Health&Fitness app publishers’ profiles
6.2 Nike, Inc
6.4 FitBit Inc,
6.6 Fitness Keeper
6.9 GP Apps
6.10 Pacer Health Inc,
7 Top 10 Medical app publishers’ profiles
7.3 Ovuline Inc,
7.5 Allscripts Health
7.9 Unbound medicine
8 mHealth app market forecast 2015-2020
8.1 mHealth user base and app downloads forecast
8.2 Market revenue forecast
8.2.1 Service revenue
8.2.2 Device revenue
8.2.4 Paid downloads
9.1 List of figures
9.2 List of tables
9.3 About research2guidance
Make an enquiry before buying this Report
Please fill the enquiry form below.
Apoptosis is a programmed natural process of cell death in the body which results from natural stimuli in order to protect against viral infection, unusual cell division and cells with damaged genetic material. However malfunctioning of apoptosis can trigger uncontrolled and non regulated cell death related to degenerative disorders such as Parkinson’s disease and Alzheimer’s. Defective apoptosis process has been one of the most c...
Circulating biomarkers are an integral part of healthcare management due to its use in performing a biopsy, monitoring progression of disease, and effectiveness of a treatment regimen. Dying tumor cells release small pieces of their DNA into the bloodstream and these pieces are called cell-free circulating biomarkers. With the help of these biomarkers, patients’ prognosis is evaluated to improve drug development and identify patients who ...
A mice model is a living mouse/mice that is usually used in any research and experiment of human related disease and its treatment regimen. Mice are the most commonly used animal in research and development activities, especially in the field of biology and psychology. This increased adoption of mice is observed in biological experiments as this organism share a high degree of homology with humans. Therefore, for better understanding the process ...